Professor John A Myburgh AO, is the Director, Professoriate at the George Institute for Global Health.

He is also Professor of Intensive Care Medicine, University of New South Wales and Senior Intensive Care Physician at the St George Hospital, Sydney.

He holds a National Health and Medical Research Council Leadership Investigator Grant Fellowship and an honorary Professorial appointment at the Monash University School of Public Health and Preventive Medicine.

He has an extensive research record of accomplishment over 30 years and is regarded as a national and international expert in catecholamine neurophysiology and pharmacology, trials of clinical management of traumatic brain injury, fluid resuscitation and in the development and co-ordination of over 40 clinical trials in Intensive Care Medicine.

He has published over 275 refereed research publications, (including 12 papers in the New England Journal of Medicine) and 45 book chapters and monographs. His current h-index is 44, calculated from 244 publications in SCOPUS, yielding over 15500 citations, with a citation trajectory of 900 to 2200 citations per annum from 2010 to the present.

He has received over $48M grant funding from the National Health and Medical Research Council. In addition to other national and international grants, total cumulative research funding to the present is over A$87M.

He has delivered over 400 presentations at national and international scientific meetings since 1994, including over 50 plenary presentations at major scientific congresses.

He is a Foundation Member and Past-Chairman of the Australian and New Zealand Intensive Care Society Clinical Trials Group. He was instrumental in the establishment of the Australian and New Zealand Intensive Care Research Centre at the Monash University School of Public Health and Preventive Medicine. 

He has made a substantive contribution to education in Intensive Care Medicine, both at undergraduate and postgraduate levels over the last 25 years. He was instrumental in establishing the College of Intensive Care Medicine, serving as a Fellowship examiner for twelve years, on the Board for ten years and as the first elected President from 2010-2012.

He is a Fellow of the Australian Academy of Health and Medical Science and served on the Council of the World Federation of Societies of Intensive and Critical Care Medicine for six years and as Secretary-General from 2017-2019.

In the 2014 Queen’s Birthday honours, he was made an Officer of the Order of Australia (AO) for distinguished service to medicine as an intensive care medical practitioner, educator and researcher, and as an international innovator in patient management

Bala Venkatesh is Director of Intensive care at the Wesley Hospital, Pre-Eminent specialist in Intensive Care Medicine at the Princess Alexandra Hospital, Brisbane, Professor of Intensive Care Medicine at the University of Queensland, and. at the University of New South Wales, and Professorial Fellow at the George Institute for Global Health, Sydney Australia. He is the Chairman of the Queensland Health Statewide Sepsis Steering Committee. He is a Fellow of the Australian Academy of Health and Medical Sciences

He has completed Fellowship training in Internal Medicine, Anaesthesia and Intensive Care Medicine.  He then undertook a research degree from the University of Birminghan, UK which led to the award of an MD.  He pioneered the development of a continuous blood gas monitoring system which reached clinical application.

He served as the President for the College of Intensive Care Medicine of Australia and New Zealand between 2014-2016.  He led the international taskforce on gender equity in Intensive Care which influenced guidelines in the World federation of Intensive Care. As President of the College of Intensive Care, he led the task force on bullying and discrimination which have informed College policy.

He led the NHMRC funded multi-center international ADRENAL trial which is largest septic shock trial to date. This was published in the New England Journal of Medicine and ranked in the top 12 articles of 2018. He has served on several  Data Safety Monitoring Committees and on the Management committee of RCTs in sepsis. His research interests include glucocorticoid physiology in critical illness including the development of the idea of the "sick euadrenal state, sepsis and vitamin D in critical illness.

In 2020, following the Covid-19 pandemic, he contributed to the REMAP-CAP steroid trial design and development and was on its writing committee recently reported in JAMA, which influenced guideline development. He was instrumental in the development of the George Institute’s Covid-19 research program in India and played a  key role in the set up of the COVID Steroid 2 trial in India which was also published in JAMA. He is currently investigating the role of fludrocortisone in septic shock.

He has published more than 250 papers, 40 book chapters, and edited 2 books. He has supervised 8 PhD students. He is now a Level 3 NHMRC Investigator Fellow.